All news

Humana analyst target implies 10.2% upside

Alpha Vantage · Barron's · · AI-summarised by FinFlash

Humana Inc. carries an average analyst price target of $465.12 against a price of $422.07, implying roughly 10.2% upside. Ratings split at 13 Buy, 12 Hold and 1 Sell. The Vienna-listed quote shows a delayed €0.00 print, with an average target of €460.46. The divided analyst view suggests limited conviction, so investors should weigh the modest upside against mixed sentiment.

Read original source

HUM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.